These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1698 related articles for article (PubMed ID: 18167216)
1. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction. Zhang X; Watson DI; Jamieson GG Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216 [TBL] [Abstract][Full Text] [Related]
2. Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Liu L; Hofstetter WL; Rashid A; Swisher SG; Correa AM; Ajani JA; Hamilton SR; Wu TT Am J Surg Pathol; 2005 Aug; 29(8):1079-85. PubMed ID: 16006804 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan. Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549 [TBL] [Abstract][Full Text] [Related]
4. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas. Ueda Y; Shiozaki A; Itoi H; Okamoto K; Fujiwara H; Ichikawa D; Kikuchi S; Fuji N; Itoh T; Ochiai T; Yamagishi H Jpn J Clin Oncol; 2006 Dec; 36(12):775-82. PubMed ID: 17043058 [TBL] [Abstract][Full Text] [Related]
5. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Gu Y; Swisher SG; Ajani JA; Correa AM; Hofstetter WL; Liao Z; Komaki RR; Rashid A; Hamilton SR; Wu TT Cancer; 2006 Mar; 106(5):1017-25. PubMed ID: 16456809 [TBL] [Abstract][Full Text] [Related]
6. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction. Ielpo B; Pernaute AS; Elia S; Buonomo OC; Valladares LD; Aguirre EP; Petrella G; Garcia AT Interact Cardiovasc Thorac Surg; 2010 May; 10(5):704-8. PubMed ID: 20154347 [TBL] [Abstract][Full Text] [Related]
7. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction. de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of the survival in patients after surgical resection of thoracic esophageal cancer]. Zhang HL; Liu RL; Shi YT; Wang ZC; Wang BH; Li YJ; Zhou LY; Ping YM Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):541-5. PubMed ID: 19950705 [TBL] [Abstract][Full Text] [Related]
9. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776 [TBL] [Abstract][Full Text] [Related]
10. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction. Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033 [TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911 [TBL] [Abstract][Full Text] [Related]
13. Adenocarcinoma of the esophagogastric junction in Japan. Yamamoto M; Baba H; Egashira A; Oki E; Ikebe M; Kakeji Y; Maehara Y Hepatogastroenterology; 2008; 55(81):103-7. PubMed ID: 18507087 [TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens. Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508 [TBL] [Abstract][Full Text] [Related]
16. [Influence of number of removed lymph nodes on the TNM staging and survival in advanced esophageal carcinoma]. Chen LQ; Hu CY; Zhang HL; He M; Meng XL; Ping YM Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):604-8. PubMed ID: 18210881 [TBL] [Abstract][Full Text] [Related]
17. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329 [TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition. Meier I; Merkel S; Papadopoulos T; Sauer R; Hohenberger W; Brunner TB Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1408-17. PubMed ID: 18374226 [TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre]. Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954 [TBL] [Abstract][Full Text] [Related]
20. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis. Wu YF; Xu HM; Chen JQ Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]